Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Preoperative Amiodarone for Prevention of Atrial Fibrillation After Lung Resection

NCT00300495 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00300495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00300495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Preoperative Amiodarone for Prevention of Atrial Fibrillation After Lung Resection
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2006
Completion date
October 13, 2009
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, lung cancer